-
Johnson&Johnson Opsynvi single tablet combination therapy approved by FDA
Johnson&Johnson announced on the 23rd that the US FDA has approved its Opsynvi monotherapy combination therapy for long-term treatment of adult patients with pulmonary arterial hypertension (PAH) cla ... -
Is the beef fillet at the small ingredient counter gone? Haidilao: Free selection available on tablets
New Beijing News (Reporter Wang Ping) Recently, some netizens claimed that "Haidilao's small ingredient platform is out of beef pellets". On July 18th, Haidilao responded to this issue by stating to ...